ATE220674T1 - 12h-dibenzo(d,g)(1,3)dioxocin derivate - Google Patents

12h-dibenzo(d,g)(1,3)dioxocin derivate

Info

Publication number
ATE220674T1
ATE220674T1 AT96930027T AT96930027T ATE220674T1 AT E220674 T1 ATE220674 T1 AT E220674T1 AT 96930027 T AT96930027 T AT 96930027T AT 96930027 T AT96930027 T AT 96930027T AT E220674 T1 ATE220674 T1 AT E220674T1
Authority
AT
Austria
Prior art keywords
dioxocin
dibenzo
derivatives
dioxocin derivatives
Prior art date
Application number
AT96930027T
Other languages
English (en)
Inventor
Rolf Hohlweg
Tine Krogh Joergensen
Knud Erik Andersen
Uffe Bang Olsen
Peter Madsen
Zendek Polivka
Otylie Koenigova
Frantisek Miksik
Martina Kovandova
Alexandra Silhankova
Karel Sindelar
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE220674T1 publication Critical patent/ATE220674T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT96930027T 1995-09-19 1996-09-12 12h-dibenzo(d,g)(1,3)dioxocin derivate ATE220674T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK104195 1995-09-19
DK104095 1995-09-19
PCT/DK1996/000382 WO1997011071A1 (en) 1995-09-19 1996-09-12 Novel heterocyclic compounds

Publications (1)

Publication Number Publication Date
ATE220674T1 true ATE220674T1 (de) 2002-08-15

Family

ID=26065121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96930027T ATE220674T1 (de) 1995-09-19 1996-09-12 12h-dibenzo(d,g)(1,3)dioxocin derivate

Country Status (22)

Country Link
US (6) US5753678A (de)
EP (1) EP0851865B1 (de)
JP (1) JP3499569B2 (de)
KR (1) KR100437561B1 (de)
CN (1) CN1090629C (de)
AR (1) AR004513A1 (de)
AT (1) ATE220674T1 (de)
AU (1) AU700784B2 (de)
BR (1) BR9610524A (de)
CA (1) CA2231835A1 (de)
CZ (1) CZ70998A3 (de)
DE (1) DE69622415T2 (de)
ES (1) ES2179206T3 (de)
HU (1) HUP9900079A3 (de)
IL (1) IL123424A (de)
MX (1) MX9802126A (de)
NO (1) NO981216L (de)
PL (1) PL186708B1 (de)
PT (1) PT851865E (de)
RU (1) RU2178790C2 (de)
TW (1) TW406078B (de)
WO (1) WO1997011071A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952352A (en) * 1995-04-07 1999-09-14 Novo Nordisk A/S Heterocyclic compounds
CN1088459C (zh) * 1996-10-04 2002-07-31 诺沃挪第克公司 1,4－二取代的哌嗪
US6040318A (en) * 1997-06-25 2000-03-21 Novo Nordisk A/S Tricycle substituted with azaheterocyclic carboxylic acids
TW200400816A (en) 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
CN101880277A (zh) 2003-04-24 2010-11-10 因塞特公司 作为金属蛋白酶抑制剂的氮杂螺烷衍生物
US7910108B2 (en) * 2006-06-05 2011-03-22 Incyte Corporation Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174126B (hu) * 1977-08-02 1979-11-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija novykh proizvodnykh dibenzo-kvadratnaja skobka-d,g-kvadratnaja skobka zakryta-kvadratnaja skobka-1,3,6-kvadratnaja skobka zakryta-dioksazocina
HU195491B (en) * 1985-12-20 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
HU201318B (en) * 1987-12-31 1990-10-28 Egyt Gyogyszervegyeszeti Gyar Process for producing dioxazoline derivatives and pharmaceutical compositions comprising same
CN1074926A (zh) * 1992-01-29 1993-08-04 大连石油化工公司有机合成厂 混合原油破乳剂的制备方法

Also Published As

Publication number Publication date
AU700784B2 (en) 1999-01-14
MX9802126A (es) 1998-05-31
NO981216D0 (no) 1998-03-18
US5753678A (en) 1998-05-19
EP0851865B1 (de) 2002-07-17
IL123424A (en) 2002-02-10
KR100437561B1 (ko) 2004-07-16
DE69622415T2 (de) 2003-03-06
HUP9900079A2 (hu) 1999-10-28
KR19990063593A (ko) 1999-07-26
EP0851865A1 (de) 1998-07-08
CN1090629C (zh) 2002-09-11
AR004513A1 (es) 1998-12-16
WO1997011071A1 (en) 1997-03-27
CN1196729A (zh) 1998-10-21
RU2178790C2 (ru) 2002-01-27
TW406078B (en) 2000-09-21
BR9610524A (pt) 1999-07-06
IL123424A0 (en) 1998-09-24
ES2179206T3 (es) 2003-01-16
PL186708B1 (pl) 2004-02-27
US5917047A (en) 1999-06-29
US5972925A (en) 1999-10-26
PT851865E (pt) 2002-11-29
DE69622415D1 (de) 2002-08-22
CZ70998A3 (cs) 1998-08-12
US5912262A (en) 1999-06-15
CA2231835A1 (en) 1997-03-27
US5916901A (en) 1999-06-29
NO981216L (no) 1998-03-18
AU6923496A (en) 1997-04-09
US6017915A (en) 2000-01-25
PL325637A1 (en) 1998-08-03
HUP9900079A3 (en) 2000-02-28
JP3499569B2 (ja) 2004-02-23
JPH11506470A (ja) 1999-06-08

Similar Documents

Publication Publication Date Title
ATE264327T1 (de) Substituierte 6,6-heterobicyclische derivate
DE69613368D1 (de) Chinazolin derivate
DE69613369D1 (de) Chinazolin derivate
DE69613367D1 (de) Chinazolin derivate
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
ATE228510T1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
NL300214I1 (nl) Chinazolinederivaten.
NO983169L (no) Hetrosykel-kondenserte morfinoidderivater (31)
DE69631774D1 (de) 2,3-dioxo-1,2,3,4-tetrahydro-chinoxalin derivate
DE69618634D1 (de) 1,4-benzodioxin-derivate
TR199600883A2 (tr) Pürin-6-on türevleri.
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
FI952424L (fi) 11,21-bisfenyyli-19-norpregaanijohdannaisia
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
DE59507222D1 (de) Substituierte 1,2,3,4-tetrahydro-5-nitro-pyrimidine
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
BR9609884A (pt) N-aril- 1,2,4-triazolin-5-onas
TR199600715A2 (tr) Kefalosforin türevleri.
ATE241599T1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalcerifer l derivate
NO961404D0 (no) 4-indolylpiperazinyl-derivater
EP0811014A4 (de) Neuartiges bakteriozin, piscicolin 126
TR199600064A2 (tr) 4-amino-benzoilguanidin-türevleri.
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
DE69636837D1 (de) 1,2,4-benzotriazinoxid-formulierungen
ATE240941T1 (de) 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee